YC P26
Astraea
Agents that accelerate clinical trials.
About
Astraea automates clinical trial biometrics from raw study inputs to FDA-ready outputs. The platform handles data normalization, CDISC mapping, SDTM, ADaM, TFLs, QC, and revision workflows in one auditable system, helping Phase II/III sponsors reduce months of manual programming and data management into automated, reviewable execution.
Founders
- Sanmay Sarada
- Joshua Wang
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Astraea.
See family office activityIndustry & Focus
B2BArtificial IntelligenceSaaSHealth Tech